American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Indivior Pharmaceuticals, Inc. (INDV)

$34.56 +0.26% NASDAQ: INDV · 15-min delayed

NORTH CHESTERFIELD, Virginia
Public · NASDAQ: INDV
838 employees

Visit website Follow

$4.8BMarket cap

$1.2BRevenue · FY2025

$210.0MNet income

838Employees

INDVNASDAQ

2014IPO

About Indivior Pharmaceuticals, Inc.

Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · NASDAQ: INDV
Employees: 838
IPO date: Dec 24, 2014
Headquarters: 10710 MIDLOTHIAN TURNPIKE
NORTH CHESTERFIELD, Virginia 23235
Phone: 804-379-1090
Industry: Pharmaceuticals
Website: Visit site

Incorporation record

Incorporated in: DE, United States
Registered office: Dover, US
Legal entity ID: 254900MKFFZZSS7N1I14

Source: GLEIF, the global Legal Entity Identifier registry · checked Jul 26, 2026. A US headquarters does not always mean US incorporation.

Registry IDs

Ticker: INDV Nasdaq
SEC CIK: 1625297
LEI: 254900MKFFZZSS7N1I14
EIN: 412520873
SIC: 2834 PHARMACEUTICAL PREPARATIONS

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show Indivior Pharmaceuticals, Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/indivior-pharmaceuticals-inc/"><img src="https://americancompanies.com/badge/indivior-pharmaceuticals-inc.svg" alt="Indivior Pharmaceuticals, Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow Indivior Pharmaceuticals, Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $1.2B
Net income: $210.0M
Total assets: $1.2B
Market cap: $4.8B

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: INDV

$34.56 +0.26%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$22.73 $41.83

52-week range

Market cap: $4.8B
Shares outstanding: 138.6M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Dec 24, 2014

Indivior Pharmaceuticals, Inc. (INDV) Stock Price

Profitable — net income of $210.0M in FY2025.
Trading 17% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Indivior Pharmaceuticals, Inc..

Write a review

Newsroom

News about Indivior Pharmaceuticals, Inc.

Global Substance Use Disorder Treatment Market Analysis and Forecast to 2030 | Long-Acting Therapies, Telemedicine, and Drug Innovation Drive Growth GlobeNewswire Inc. · 2026-10-02 · positive Halper Sadeh LLC is Investigating Whether ITGR, FHB, INDV, LNTH are Obtaining Fair Deals for their Shareholders GlobeNewswire Inc. · 2026-09-30 · negative Indivior Pharmaceuticals Inc. (INDV) Down 5.3% Since Last Earnings Report: Can It Rebound? Zacks Investment Research · 2026-09-02 · positive Why Supernus Pharmaceuticals Stock Topped the Market Today The Motley Fool · 2026-08-03 · negative Indivior to Report Second Quarter 2026 Financial Results and Host Webcast GlobeNewswire Inc. · 2026-07-23 · positive Herantis reports positive FDA feedback and finalizes Phase 2a study design for HER-096 GlobeNewswire Inc. · 2026-06-02 · positive

News & sentiment via Polygon.io

FAQ

Indivior Pharmaceuticals, Inc.: frequently asked questions

Is Indivior Pharmaceuticals, Inc. an American company?

Indivior Pharmaceuticals, Inc. is a US-based company headquartered in North Chesterfield, Virginia, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Indivior Pharmaceuticals, Inc. headquartered?

Indivior Pharmaceuticals, Inc. is headquartered in North Chesterfield, Virginia, United States.

Is Indivior Pharmaceuticals, Inc. publicly traded?

Yes — Indivior Pharmaceuticals, Inc. is a publicly traded company. Its stock trades under the ticker symbol INDV on the NASDAQ.

What does Indivior Pharmaceuticals, Inc. do?

Indivior Pharmaceuticals, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore